Nuclear Medicine: Page 31

FDG-PET/CT predicts severity of COVID-19 infection

By Will Morton

FDG-PET/CT imaging in patients diagnosed with COVID-19 is associated with a higher risk of symptomatic infection and hospitalization, which may help predict disease severity, according to a study published August 8 in Clinical Imaging.

August 10, 2021

Q BioMed signs Canadian distributor for Strontium89

By AuntMinnie.com staff writers

Biotech company Q BioMed has signed an exclusive distribution agreement for its Strontium89 therapeutic radiopharmaceutical with Canadian distributor isoSolutions Marketing & Management.

August 9, 2021

GE set to supply iodine-123 to NorthStar

By AuntMinnie.com staff writers

GE Healthcare has inked an exclusive manufacturing and distribution agreement with NorthStar Medical Radioisotopes to manufacture and distribute iodine-123 capsules in the U.S.

August 2, 2021

ImaginAb signs new agreement with Boehringer Ingelheim

By AuntMinnie.com staff writers

ImaginAb has signed a new license agreement to supply its ImmunoPET radiotracer to Boehringer Ingelheim.

July 22, 2021

International Isotopes snaps up remaining RadQual shares

By AuntMinnie.com staff writers

Radioisotope manufacturer International Isotopes has purchased all remaining shares in its subsidiary RadQual, completing a transaction that began in 2017.

July 11, 2021

FDG-PET identifies biomarkers in dementia with Lewy bodies

By Will Morton

FDG-PET can identify whether mild cognitive impairment is associated with dementia with Lewy bodies or with Alzheimer's disease, two neurodegenerative conditions that can be indistinguishable in later stages, according to a study published July 4 in NeuroImage: Clinical.

July 7, 2021

Ga-68 PSMA-11 improves outcomes in prostate cancer patients

By Will Morton

PET with a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA)-11 radiotracer should be the standard imaging modality for guiding stereotactic ablative radiotherapy in oligometastatic prostate cancer patients, according to a June 29 study in Clinical and Translational Radiation Oncology.

July 1, 2021

AuntMinnie.com Molecular Imaging Insider

By Will Morton

June 29, 2021

Tau PET bests amyloid PET, MRI in Alzheimer's prognostic study

By Will Morton

Tau PET is superior to amyloid PET and MRI for detecting cognitive decline in Alzheimer's disease patients over time and may serve as a prognostic tool to help manage patients in the early stages of the disease, according to a study published June 28 in JAMA Neurology.

June 28, 2021

RayzeBio, Nimble ink research collaboration

By AuntMinnie.com staff writers

RayzeBio and Nimble Therapeutics plan to collaborate on the discovery and development of novel peptide-based radiopharmaceuticals for cancer treatment.

June 27, 2021

Telix, Monrol reach agreement on therapeutic isotope supply

By AuntMinnie.com staff writers

Telix Pharmaceuticals has signed a global clinical supply agreement with Istanbul-based Eczacıbaşı-Monrol Nuclear Products (Monrol) for the supply of no-carrier-added lutetium-177, a therapeutic isotope used in Telix's portfolio of molecularly targeted radiation products.

June 27, 2021

Researchers report on PET/CT's COVID-19 pandemic performance

By Will Morton

When it comes to imaging diseases like COVID-19, FDG-PET/CT may not be the first modality that springs to mind. But its performance over the past year for identifying infection and inflammation in COVID-19 patients offers strong evidence of its value.

June 27, 2021

Previous Page

Page 31 of 438

Next Page